Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Successful withdrawal of long-term epoprostenol therapy for pulmonary arterial hypertension.

Successful withdrawal of long-term epoprostenol therapy for pulmonary arterial hypertension. Chest. 2003 Oct; 124(4):1612-5.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.